@prefix dc1: <http://purl.org/dc/terms/> .
@prefix this: <http://purl.org/np/RA8p5TUm5XsDgqbw13nZ_dhCYZZ_cQDkcvh1LDegJT4ZY> .
@prefix sub: <http://purl.org/np/RA8p5TUm5XsDgqbw13nZ_dhCYZZ_cQDkcvh1LDegJT4ZY#> .
@prefix schema: <https://schema.org/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix nt: <https://w3id.org/np/o/ntemplate/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix orcid: <https://orcid.org/> .
@prefix bl: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
  this: np:hasAssertion sub:assertion ;
    np:hasProvenance sub:provenance ;
    np:hasPublicationInfo sub:pubinfo ;
    a np:Nanopublication .
}
sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_289> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_289> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB01406> ;
    a rdf:Statement ;
    rdfs:label "endometriosis danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management fibrocystic breast disease most cases of symptomatic fibrocystic breast disease may be treated by simple measures e g padded brassieres and analgesics in infrequent patients symptoms of pain and tenderness may be severe enough to warrant treatment by suppression of ovarian function danazol capsules are usually effective in decreasing nodularity pain and tenderness it should be stressed to the patient that this treatment is not innocuous in that it involves considerable alterations of hormone levels and that recurrence of symptoms is very common after cessation of therapy hereditary angioedema danazol capsules are indicated for the prevention of attacks of angioedema of all types cutaneous abdominal laryngeal in males and females" ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:TreatmentIndication .
  <https://identifiers.org/drugbank:DB01406> bl:category bl:Drug .
}
sub:provenance {
  sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
  sub:sig npx:hasAlgorithm "RSA" ;
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
    npx:hasSignature "R+jhnaMs0RaJJIFSZ+Nr4/P3+cm/FArl0WmQysDMpyTqTK6ou8hX73x7tYh22yIYa6V3uD2oPcXoMFVBIDZYIE43KyvjoV0fqGeUCMKix2kAFXPFs+C8s53H5dwclENhXG4h3KRH5lJzl+Nnko7c4tyymitZYHuXfDMBKdSh12k=" ;
    npx:hasSignatureTarget this: .
  this: dc1:created "2021-06-13T12:22:10.491+02:00"^^xsd:dateTime ;
    dc1:creator orcid:0000-0002-1468-3557 ;
    nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM> ;
    nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM> ;
    nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> .
}